Showing 3491-3500 of 7016 results for "".
Window to the Diabetic Patient's Life: An Endocrinologist's Shared Experience
https://reachmd.com/programs/clinicians-roundtable/window-to-the-diabetic-patients-life-an-endocrinologists-shared-experience/7003/As health care providers, despite our knowledge and empathy of patient experiences, we may become distanced from the day-to-day life of coping with chronic diseases such as diabetes. Host Dr. Prathima Setty welcomes Dr. Svetlana Katsnelson, an Endocrinology Fellow from Stony Brook University MedicalCurrent Inquiries in Lipidology: The NLA's Role in the Field
https://reachmd.com/programs/lipid-luminations/current-inquiries-in-lipidology-the-nlas-role-in-the-field/6297/From reversing atherosclerosis with HDL modification to promising antibodies on the horizon for lowering LDL cholesterol, the science of lipidology is a quickly-evolving field. What is the role of the National Lipid Association in clinical practice for clinicians who may not be lipid specialists? HPharma and Biotech Industries Pursue Treatments for Cardiac Inflammation
https://reachmd.com/programs/clinicians-roundtable/pharma-and-biotech-industries-pursue-treatments-for-cardiac-inflammation/3660/A treatment for atherosclerosis and the chronic inflammation in arterial blood vessels could be entering critical clinical trial stages that may result in a novel new treatment. Dr. Lawrence Cohen, president and chief executive officer of VIA Pharmaceuticals lays out for host ChiThe Latest Targets of Lipid Therapy
https://reachmd.com/programs/lipid-luminations/the-latest-targets-of-lipid-therapy/3182/Host Dr. Larry Kaskel welcomes Dr. Alan Brown, medical director of the Midwest Heart Disease Prevention Center in Naperville, Illinois, to discuss targets of lipid therapy. What are the calculated risk assessments for major cardiovascular events among patients with coronary disease, diabetes and othUnderstanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://reachmd.com/series/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC
https://reachmd.com/programs/cme/translating-clinical-data-into-multidisciplinary-practice-for-es-sclc/37878/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.A Critical View of JUPITER
https://reachmd.com/programs/lipid-luminations/a-critical-view-of-jupiter/4124/Results from the recent JUPITER trial demonstrated that high-sensitivity C-reactive protein tests were strikingly effective at identifying patients whose risk of cardiovascular events and mortality could be significantly lowered with statin treatment. But do these results warrant broader screening fCardiac Arrest: When Should EMS Scoop and Run?
https://reachmd.com/programs/clinicians-roundtable/cardiac-arrest-when-should-ems-scoop-and-run/4062/EMS care has advanced since the first ambulances scooped a patient up and ran to the hospital. But is it time to go back to BLS? Dr Marianne Gauche-Hill, Director of EMS at UCLA Harbor and Professor of Medicine at UCLA, discusses research from Canada and the US showing that for certain diagnosis, EMThe Importance of Non-HDL Cholesterol Testing
https://reachmd.com/programs/lipid-luminations/the-importance-of-non-hdl-cholesterol-testing/3705/Dr. Terry A. Jacobson explains to host Dr. Larry Kaskel the importance of non-HDL cholesterol reporting in lipid management. Dr. Jacobson describes additional lipid parameters that are emerging as valuable adjuncts to the standard panel, including measurements of apolipopprtoeins and LDL particle siCan Men Increase Their Longevity?
https://reachmd.com/programs/clinicians-roundtable/can-men-increase-their-longevity/2779/Women live longer than men, even in the poorest countries. This statistic from a 2006 article in The British Medical Journal was the topic of our discussion with guest Dr. Ken Brummel-Smith, Professor in the department of Geriatrics at Florida State University College of Medicine. He and host, Dr. B